Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$354 Mln
P/E Ratio
7.18
P/B Ratio
1.43
Industry P/E
--
Debt to Equity
0
ROE
0.27 %
ROCE
27.02 %
Div. Yield
0 %
Book Value
28.84
EPS
5.11
CFO
$75.04 Mln
EBITDA
$77.68 Mln
Net Profit
$69.16 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Semler Scientific Inc (SMLR)
| -31.78 | -14.09 | -33.57 | 38.39 | -6.69 | -3.45 | 25.66 |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Semler Scientific Inc (SMLR)
| 21.73 | 34.21 | -63.99 | -2.50 | 95.83 | 39.53 | 326.60 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.93 | 10,562.04 | 12.43 | 12.69 | |
| 72.80 | 10,050.19 | 97.07 | 2.52 | |
| 163.74 | 8,847.72 | -- | -25.23 | |
| 299.78 | 11,550.00 | 278.74 | 3.65 |
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables... healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. Read more
CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary
Ms. Renae Cormier
CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary
Ms. Renae Cormier
Headquarters
Santa Clara, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Semler Scientific Inc (SMLR) stood at $ 240 Mln as on 31-Dec-24
The share price of Semler Scientific Inc (SMLR) is $36.84 (NASDAQ) as of 25-Apr-2025 16:22 EDT. Semler Scientific Inc (SMLR) has given a return of -6.69% in the last 3 years.
Semler Scientific Inc (SMLR) has a market capitalisation of $ 354 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Semler Scientific Inc (SMLR) is 7.18 times as on 25-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Semler Scientific Inc (SMLR) and enter the required number of quantities and click on buy to purchase the shares of Semler Scientific Inc (SMLR).
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
The CEO & director of Ms. Renae Cormier. is Semler Scientific Inc (SMLR), and CFO & Sr. VP is Ms. Renae Cormier.
There is no promoter pledging in Semler Scientific Inc (SMLR).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,078
|
|
|
1,054
|
|
|
964
|
|
|
853
|
| Semler Scientific Inc (SMLR) | Ratios |
|---|---|
|
Return on equity(%)
|
27.04
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
72.65
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Semler Scientific Inc (SMLR) was $0 Mln.
$2.40
(
